383 related articles for article (PubMed ID: 24969924)
1. Neurosurgical oncology: advances in operative technologies and adjuncts.
D'Amico RS; Kennedy BC; Bruce JN
J Neurooncol; 2014 Sep; 119(3):451-63. PubMed ID: 24969924
[TBL] [Abstract][Full Text] [Related]
2. Optimizing glioblastoma resection: intraoperative mapping and beyond.
Osorio JA; Aghi MK
CNS Oncol; 2014; 3(5):359-66. PubMed ID: 25363008
[TBL] [Abstract][Full Text] [Related]
3. The value of extent of resection of glioblastomas: clinical evidence and current approach.
Almeida JP; Chaichana KL; Rincon-Torroella J; Quinones-Hinojosa A
Curr Neurol Neurosci Rep; 2015; 15(2):517. PubMed ID: 25467408
[TBL] [Abstract][Full Text] [Related]
4. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.
Hauser SB; Kockro RA; Actor B; Sarnthein J; Bernays RL
Neurosurgery; 2016 Apr; 78(4):475-83. PubMed ID: 26407129
[TBL] [Abstract][Full Text] [Related]
5. Role of 5-ALA in improving extent of tumour resection in patients with Glioblastoma Multiforme.
Waqas M; Khan I; Shamim MS
J Pak Med Assoc; 2017 Oct; 67(10):1630-1632. PubMed ID: 28955092
[TBL] [Abstract][Full Text] [Related]
6. Novel strategies in glioblastoma surgery aim at safe, supra-maximum resection in conjunction with local therapies.
Wolbers JG
Chin J Cancer; 2014 Jan; 33(1):8-15. PubMed ID: 24384236
[TBL] [Abstract][Full Text] [Related]
7. Current surgical management of glioblastoma.
Hentschel SJ; Lang FF
Cancer J; 2003; 9(2):113-25. PubMed ID: 12784877
[TBL] [Abstract][Full Text] [Related]
8. Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance.
Neira JA; Ung TH; Sims JS; Malone HR; Chow DS; Samanamud JL; Zanazzi GJ; Guo X; Bowden SG; Zhao B; Sheth SA; McKhann GM; Sisti MB; Canoll P; D'Amico RS; Bruce JN
J Neurosurg; 2017 Jul; 127(1):111-122. PubMed ID: 27715437
[TBL] [Abstract][Full Text] [Related]
9. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
[TBL] [Abstract][Full Text] [Related]
10. Low field intraoperative MRI-guided surgery of gliomas: a single center experience.
Senft C; Franz K; Ulrich CT; Bink A; Szelényi A; Gasser T; Seifert V
Clin Neurol Neurosurg; 2010 Apr; 112(3):237-43. PubMed ID: 20036049
[TBL] [Abstract][Full Text] [Related]
11. [Surgery of high-grade gliomas guided by fluorescence: a retrospective study of 22 patients].
Jacquesson T; Ducray F; Maucort-Boulch D; Armoiry X; Louis-Tisserand G; Mbaye M; Pelissou-Guyotat I; Guyotat J
Neurochirurgie; 2013 Feb; 59(1):9-16. PubMed ID: 23318102
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival after glioblastoma resection: hope despite poor prognosis factors.
Costa E; Lawson TM; Lelotte J; Fomekong E; Vaz RG; Renard L; Whenham N; Raftopoulos C
J Neurosurg Sci; 2019 Jun; 63(3):251-257. PubMed ID: 29363298
[TBL] [Abstract][Full Text] [Related]
13. Multimodal navigation in the functional microsurgical resection of intrinsic brain tumors located in eloquent motor areas: role of tractography.
González-Darder JM; González-López P; Talamantes F; Quilis V; Cortés V; García-March G; Roldán P
Neurosurg Focus; 2010 Feb; 28(2):E5. PubMed ID: 20121440
[TBL] [Abstract][Full Text] [Related]
14. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
[TBL] [Abstract][Full Text] [Related]
15. Advances in Glioblastoma Operative Techniques.
Bander ED; Magge R; Ramakrishna R
World Neurosurg; 2018 Aug; 116():529-538. PubMed ID: 30049047
[TBL] [Abstract][Full Text] [Related]
16. Estimation of brain deformation for volumetric image updating in protoporphyrin IX fluorescence-guided resection.
Valdés PA; Fan X; Ji S; Harris BT; Paulsen KD; Roberts DW
Stereotact Funct Neurosurg; 2010; 88(1):1-10. PubMed ID: 19907205
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
[TBL] [Abstract][Full Text] [Related]
18. Intra-operative MRI (iop-MR) for brain tumour surgery.
Foroglou N; Zamani A; Black P
Br J Neurosurg; 2009 Feb; 23(1):14-22. PubMed ID: 19234904
[TBL] [Abstract][Full Text] [Related]
19. Extent of Resection in Glioma-A Review of the Cutting Edge.
D'Amico RS; Englander ZK; Canoll P; Bruce JN
World Neurosurg; 2017 Jul; 103():538-549. PubMed ID: 28427971
[TBL] [Abstract][Full Text] [Related]
20. Fluorescein Sodium in the Surgical Treatment of Recurrent Glioblastoma Multiforme.
Höhne J; Schebesch KM; de Laurentis C; Akçakaya MO; Pedersen CB; Brawanski A; Poulsen FR; Kiris T; Cavallo C; Broggi M; Ferroli P; Acerbi F
World Neurosurg; 2019 May; 125():e158-e164. PubMed ID: 30682505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
